Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer (original) (raw)

Abstract

The potential anti-senescence gene Klotho (KL) has been recently found to participate in the progression of several different human cancers including breast, lung, and cervical cancer. In this current study, we identified KL as a candidate tumor suppressor gene silenced through promoter hypermethylation in colorectal cancer (CRC). KL gene expression is found to be absent or reduced in colon cancer cell lines (5/6, 83.3%), which can be reversed by treatment with demethylation agent 5-aza-2′-deoxycytidine (Aza), but not HDAC inhibitor trichostatin A. In addition, KL expression is markedly downregulated in colorectal carcinoma tissues when compared to the adjacent nontumor tissues (n = 25, p < 0.001). The methylation of the KL gene promoter was frequently detected in primary tumor tissues (34/40, 85%) when compared with adjacent nontumor colon tissues. Furthermore, ectopic expression of KL led to the cell proliferation inhibition of colon cancer cell lines via the induction of cell apoptosis and S-phase cell cycle arrest. Taken together, our results suggest that KL is inactivated through promoter hypermethylation and potentially functions as a tumor suppressor gene in CRC.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.
    Article PubMed Google Scholar
  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.
    Article PubMed Google Scholar
  3. Ahnen DJ. The american college of gastroenterology emily couric lecture—the adenoma–carcinoma sequence revisited: has the era of genetic tailoring finally arrived? Am J Gastroenterol. 2011;106:190–8.
    Article PubMed Google Scholar
  4. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079–99.
    Article PubMed CAS Google Scholar
  5. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut. 2007;56:140–8.
    Article PubMed CAS Google Scholar
  6. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148–59.
    Article PubMed CAS Google Scholar
  7. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683–92.
    Article PubMed CAS Google Scholar
  8. Ang PW, Loh M, Liem N, Lim PL, Grieu F, et al. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer. 2010;10:227–34.
    Article PubMed Google Scholar
  9. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res. 2005;11:1203–9.
    PubMed CAS Google Scholar
  10. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525–30.
    PubMed CAS Google Scholar
  11. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009;15:6185–91.
    Article PubMed CAS Google Scholar
  12. Wang LJ, Jin HC, Wang X, Lam EK, Zhang JB, Liu X, et al. ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem Biophys Res Commun. 2009;379:959–63.
    Article PubMed CAS Google Scholar
  13. Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, et al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 2010;29:442–50.
    Article PubMed CAS Google Scholar
  14. Liu X, Lam EK, Wang X, Zhang J, Cheng YY, Lam YW, et al. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. Tumour Biol. 2009;30:242–8.
    Article PubMed Google Scholar
  15. Wang X, Lau KK, So LK, Lam YW. CHD5 is down-regulated through promoter hypermethylation in gastric cancer. J Biomed Sci. 2009;16:95.
    Article PubMed CAS Google Scholar
  16. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45–51.
    Article PubMed CAS Google Scholar
  17. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829–33.
    Article PubMed CAS Google Scholar
  18. Wang YA. Klotho, the long sought-after elixir and a novel tumor suppressor? Cancer Biol Ther. 2006;5:20–1.
    PubMed CAS Google Scholar
  19. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene. 2008;27:7094–105.
    Article PubMed CAS Google Scholar
  20. Chen B, Wang X, Zhao W, Wu J. Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res. 2010;29:99–106.
    Article PubMed Google Scholar
  21. Lee J, Jeong DJ, Kim J, Lee S, Park JH, Chang B, et al. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer. 2010;9:109–18.
    Article PubMed Google Scholar
  22. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475–85.
    Article PubMed CAS Google Scholar
  23. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer. 2010;10:51–7.
    Article PubMed CAS Google Scholar
  24. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915–28.
    Article PubMed CAS Google Scholar
  25. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut. 2002;50:642–6.
    Article PubMed CAS Google Scholar
  26. Yavari K, Taghikhani M, Ghannadi Maragheh M, Mesbah-Namin SA, Babaei MH. Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells. Int J Colorectal Dis. 2010;25:9–16.
    Article PubMed Google Scholar
  27. de Oliveira RM. Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett. 2006;580:5753–8.
    Article PubMed Google Scholar
  28. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007;317:803–6.
    Article PubMed CAS Google Scholar
  29. Wang LJ, Wang X, Wang XJ, Pan J, Zhang SJ, et al. Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res. 2011;1:111–9.
    CAS Google Scholar
  30. Groden J. Touch and go: mediating cell-to-cell interactions and Wnt signaling in gastrointestinal tumor formation. Gastroenterology. 2004;119:1161–4.
    Article Google Scholar
  31. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007;56:417–25.
    Article PubMed CAS Google Scholar

Download references

Acknowledgments

The study was supported by the National Natural Scientific Foundation of China (30900676,81071963). We thank Dr. Manish Gala and Prof/Dr. Georg Enders for critical review and editing of the manuscript.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Jie Pan, Jing Zhong, Li Hong Gan & Liang Jing Wang
  2. Laboratory of Digestive Disease, Clinical Institution of Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
    Jie Pan & Shu Jie Chen
  3. Key Laboratory of Biotherapy of Zhejiang Province, Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine Zhejiang University, Hangzhou, China
    Hong Chuan Jin & Xian Wang

Authors

  1. Jie Pan
    You can also search for this author inPubMed Google Scholar
  2. Jing Zhong
    You can also search for this author inPubMed Google Scholar
  3. Li Hong Gan
    You can also search for this author inPubMed Google Scholar
  4. Shu Jie Chen
    You can also search for this author inPubMed Google Scholar
  5. Hong Chuan Jin
    You can also search for this author inPubMed Google Scholar
  6. Xian Wang
    You can also search for this author inPubMed Google Scholar
  7. Liang Jing Wang
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toXian Wang or Liang Jing Wang.

Additional information

Jie Pan and Jing Zhong contributed equally to this work.

Rights and permissions

About this article

Cite this article

Pan, J., Zhong, J., Gan, L.H. et al. Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer.Tumor Biol. 32, 729–735 (2011). https://doi.org/10.1007/s13277-011-0174-5

Download citation

Keywords